Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06443944
Status:
AVAILABLE
Last Update Posted:
2024-06-05
First Post:
2024-05-30
Brief Title:
An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG
Sponsor:
CG Oncology Inc
Organization:
CG Oncology Inc
Organization Data
Organization:
CG Oncology Inc
Class:
INDUSTRY
Study ID:
CRETO-EAP
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
CG Oncology Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None